Zhaoke Ophthalmology Announces Positive Top-line Results from NVK002 Phase III One-year Clinical Trial (Mini-CHAMP) in China for the Treatment of Myopia Progression in Children
Zhaoke Ophthalmology’s Partner Vyluma Announces Positive Results from Second Stage of Phase III CHAMP Study of NVK002 for Treatment of Myopia in Children